Cargando…
AMPK: Potential Therapeutic Target for Ischemic Stroke
5'-AMP-activated protein kinase (AMPK), a member of the serine/threonine (Ser/Thr) kinase group, is universally distributed in various cells and organs. It is a significant endogenous defensive molecule that responds to harmful stimuli, such as cerebral ischemia, cerebral hemorrhage, and, neuro...
Autores principales: | Jiang, Shuai, Li, Tian, Ji, Ting, Yi, Wei, Yang, Zhi, Wang, Simeng, Yang, Yang, Gu, Chunhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134933/ https://www.ncbi.nlm.nih.gov/pubmed/30214637 http://dx.doi.org/10.7150/thno.25674 |
Ejemplares similares
-
New insights into Sirt1: potential therapeutic targets for the treatment of cerebral ischemic stroke
por: Tang, Hao, et al.
Publicado: (2023) -
AMPK: a novel target for treating hepatic fibrosis
por: Liang, Zhenxing, et al.
Publicado: (2017) -
Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility
por: Li, Chen, et al.
Publicado: (2018) -
Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke
por: Zhang, Wan, et al.
Publicado: (2020) -
Tau as a potential therapeutic target for ischemic stroke
por: Chen, Xin, et al.
Publicado: (2019)